13C MR imaging of methionine-rich gliomas at 4.7T: a pilot study

Magn Reson Med Sci. 2011;10(2):139-42. doi: 10.2463/mrms.10.139.

Abstract

We explored the feasibility of using carbon-13 ((13)C) magnetic resonance imaging ((13)C-MRI) to depict (13)C-labeled methionine-enriched gliomas at 4.7 tesla. We transplanted 2 types of glioma cells separately to 2 subcutaneous tissue sites on the backs of mice weighing 15 to 20 g. After confirming tumor growth, we used (13)C-MRI and (1)H-MRI to scan 4 mice that had been administered (13)C-labeled methionine and 2 control mice. (13)C-MRI of all 4 transplanted mice administered with (13)C-labeled methionine revealed 2 areas of hyperintensity that corresponded to the tumor sites on (1)H-MR images, but no such areas were visualized in transplanted controls. Our data suggest that (13)C-MRI can show the accumulation of (13)C-labeled tracer by gliomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Neoplasms / metabolism*
  • Carbon Isotopes
  • Feasibility Studies
  • Glioma / metabolism*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Methionine / metabolism
  • Mice
  • Mice, SCID
  • Neoplasm Transplantation
  • Pilot Projects

Substances

  • Carbon Isotopes
  • Methionine